Showing results (41-50 of 80) with videos related to
Sort By:
Pageof 8
The International Journal of Health Planning and Management|October 1, 2021
Individuals' personal characteristics associated with private health insurance policy possession in GreeceNikos Nomikos, Panagiota Naoum, Vasiliki Naoum, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|December 16, 2014
Quantifying the economic benefits of prevention in a healthcare setting with severe financial constraints: the case of hypertension controlKostas Athanasakis, Ilias-Ioannis Kyriopoulos, Nadia Boubouchairopoulou, et al.Annals of General Psychiatry|August 30, 2008
Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness studyMaria Geitona, Hara Kousoulakou, Markos Ollandezos, et al.BMC Neurology|June 5, 2013
Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare settingKostas Athanasakis, Ioannis Petrakis, Eleftheria Karampli, et al.Health Care Management Science|April 28, 2015
Measuring the efficiency of the Greek rural primary health care using a restricted DEA model; the case of southern and western GreeceNikolaos Oikonomou, Yannis Tountas, Argiris Mariolis, et al.Clinical Therapeutics|April 29, 2017
Cost-effectiveness of Ingenol Mebutate Gel for the Treatment of Actinic Keratosis in GreeceKostas Athanasakis, Nadia Boubouchairopoulou, Filippos Tarantilis, et al.Clinical Therapeutics|February 1, 2012
Cost-effectiveness analysis of ranibizumab versus verteporfin photodynamic therapy, pegaptanib sodium, and best supportive care for the treatment of age-related macular degeneration in GreeceKostas Athanasakis, Vasilios Fragoulakis, Vasiliki Tsiantou, et al.Current Medical Research and Opinion|December 7, 2021
A 10-year economic analysis of HIV management in Greece: evidence of efficient resource allocationKostas Athanasakis, Vasiliki Naoum, Panagiota Naoum, et al.Rheumatology International|March 22, 2015
Cost-utility analysis of tocilizumab monotherapy in first line versus standard of care for the treatment of rheumatoid arthritis in GreeceKostas Athanasakis, Filippos Tarantilis, Konstantina Tsalapati, et al.Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|May 28, 2014
A short-term cost-effectiveness analysis of hypertension treatment in GreeceKostas Athanasakis, Kyriakos Souliotis, Yannis Tountas, et al.Pageof 8